3,454
Views
44
CrossRef citations to date
0
Altmetric
Clinical Study

Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy

, , , , , , , & show all
Pages 243-251 | Received 18 Aug 2017, Accepted 15 Mar 2018, Published online: 10 Apr 2018

Figures & data

Figure 1. Flowchart of study participants.

Figure 1. Flowchart of study participants.

Figure 2. Representative examples of different glomerular classes in DN. (A) Mild changes by light microscopy (Class I). (B) GBM thickening by electron microscopy (Class I, scale bar = 2.0 μm). (C) Mild mesangial expansion (Class IIa). (D) Severe mesangial expansion (Class IIb). (E) Kimmelstiel–Wilson lesion (Class III). (F) Global glomerulosclerosis (Class IV).

Figure 2. Representative examples of different glomerular classes in DN. (A) Mild changes by light microscopy (Class I). (B) GBM thickening by electron microscopy (Class I, scale bar = 2.0 μm). (C) Mild mesangial expansion (Class IIa). (D) Severe mesangial expansion (Class IIb). (E) Kimmelstiel–Wilson lesion (Class III). (F) Global glomerulosclerosis (Class IV).

Table 1. Baseline demographics in the cross-section and cohort studies.

Table 2. Pathological findings according to diabetic retinopathy.

Figure 3. Risk factors for DR identified by multivariate binary logistic regression analysis. Ref indicated reference group. aAdjusting for baseline proteinuria, hematuria, e-GFR, and interstitial inflammation.

Figure 3. Risk factors for DR identified by multivariate binary logistic regression analysis. Ref indicated reference group. aAdjusting for baseline proteinuria, hematuria, e-GFR, and interstitial inflammation.

Figure 4. Kaplan–Meier curves of renal survival rate in DN patients with or without DR.

Figure 4. Kaplan–Meier curves of renal survival rate in DN patients with or without DR.

Figure 5. HRs of progression to ESRD for the patients with DN + DR versus DN only in the cohort study using univariate/multivariate COX hazard analysis. CI: confidence interval; HR: hazard ratio; Model 1: adjusted for age, gender, hypertension, cigarette smoking and the duration of T2DM at the time of renal biopsy; Model 2: adjusted for all of the above covariates plus HbA1c, hematuria and serum creatinine; Model 3: adjusted for the clinical variables in model 2 and other renal pathological findings, such as the glomerular class and interstitial inflammation score.

Figure 5. HRs of progression to ESRD for the patients with DN + DR versus DN only in the cohort study using univariate/multivariate COX hazard analysis. CI: confidence interval; HR: hazard ratio; Model 1: adjusted for age, gender, hypertension, cigarette smoking and the duration of T2DM at the time of renal biopsy; Model 2: adjusted for all of the above covariates plus HbA1c, hematuria and serum creatinine; Model 3: adjusted for the clinical variables in model 2 and other renal pathological findings, such as the glomerular class and interstitial inflammation score.